T4 RNA Ligase 1(10U/ul)
Cat. No. T41-E5143
- Escherichia phage T4（1）
No data
- His Tag（1）
No data
- E. coli（1）
No data
- Unconjugated（1）
No data
- RUO（1）
No data
- No（1）
No data
- 1000U/$68.00
- 5000U/$299.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| T4 RNA Ligase 1 | T4 RNA Ligase 1(10U/ul) | Escherichia phage T4 | E. coli | SDS-PAGE | $68.00 1000U |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Itolizumab | T-1-hT; EQ-001; T-1-h; h-T1; Bmab-600 | Approved | Biocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co Ltd | Alzumab | India | Plaque psoriasis | Biocon Ltd | 2013-01-01 | Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis | Details |